Synthesis and Biological Evaluation of ortho-Aryl N-Hydroxycinnamides as Potent Histone Deacetylase (HDAC) 8 Isoform-Selective Inhibitors

Wei Jan Huang, Yi Ching Wang, Shi Wei Chao, Chen Yui Yang, Liang Chieh Chen, Mei Hsiang Lin, Wen Chi Hou, Mei Yu Chen, Tai Lin Lee, Ping Yang, Chung I. Chang

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Histone deacetylases (HDACs) are a family of enzymes that play a crucial role in biological process and diseases. In contrast to other isozymes, HDAC8 is uniquely incapable of histone acetylation. In order to delineate its physiological function, we developed HDAC8-selective inhibitors using knowledge-based design combined with structural modeling techniques. Enzyme inhibitory analysis demonstrated that some of the resulting compounds (22b, 22d, 22f, and 22g) exhibited anti-HDAC8 activity superior to PCI34051, a known HDAC8-specific inhibitor, with IC50 values in the range of 5-50nM. Among them, compound 22d showed antiproliferative effects toward several human lung cancer cell lines (A549, H1299, and CL1-5); it exhibited cytotoxicity against human lung CL1-5 cells similar to that of SAHA yet without significant cytotoxicity for normal IMR-90 cells. Expression profiling of HDAC isoforms in three cancer cell lines indicated that the HDAC8 level in CL1-5 is higher than that in H1299 and CL1-1 cells, a result consistent with the differential cytotoxicity of compound 22d. These results suggest the effectiveness of our design concept, which may lead to a tool compound for studying the specific role of HDAC8 in cellular biological processes.

Original languageEnglish
Pages (from-to)1815-1824
Number of pages10
JournalChemMedChem
Volume7
Issue number10
DOIs
Publication statusPublished - Oct 2012

Fingerprint

Histone Deacetylases
Cytotoxicity
Biological Phenomena
Protein Isoforms
Cells
Acetylation
Enzymes
Histones
Isoenzymes
Inhibitory Concentration 50
Lung Neoplasms
Cell Line
Lung
Neoplasms

Keywords

  • Cinnamides
  • Epigenetics
  • Histone deacetylases
  • Isoform-selective inhibitors
  • Molecular modeling

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Organic Chemistry
  • Molecular Medicine

Cite this

Synthesis and Biological Evaluation of ortho-Aryl N-Hydroxycinnamides as Potent Histone Deacetylase (HDAC) 8 Isoform-Selective Inhibitors. / Huang, Wei Jan; Wang, Yi Ching; Chao, Shi Wei; Yang, Chen Yui; Chen, Liang Chieh; Lin, Mei Hsiang; Hou, Wen Chi; Chen, Mei Yu; Lee, Tai Lin; Yang, Ping; Chang, Chung I.

In: ChemMedChem, Vol. 7, No. 10, 10.2012, p. 1815-1824.

Research output: Contribution to journalArticle

Huang, Wei Jan ; Wang, Yi Ching ; Chao, Shi Wei ; Yang, Chen Yui ; Chen, Liang Chieh ; Lin, Mei Hsiang ; Hou, Wen Chi ; Chen, Mei Yu ; Lee, Tai Lin ; Yang, Ping ; Chang, Chung I. / Synthesis and Biological Evaluation of ortho-Aryl N-Hydroxycinnamides as Potent Histone Deacetylase (HDAC) 8 Isoform-Selective Inhibitors. In: ChemMedChem. 2012 ; Vol. 7, No. 10. pp. 1815-1824.
@article{43892d7581914c6a875d8ceba7a869d4,
title = "Synthesis and Biological Evaluation of ortho-Aryl N-Hydroxycinnamides as Potent Histone Deacetylase (HDAC) 8 Isoform-Selective Inhibitors",
abstract = "Histone deacetylases (HDACs) are a family of enzymes that play a crucial role in biological process and diseases. In contrast to other isozymes, HDAC8 is uniquely incapable of histone acetylation. In order to delineate its physiological function, we developed HDAC8-selective inhibitors using knowledge-based design combined with structural modeling techniques. Enzyme inhibitory analysis demonstrated that some of the resulting compounds (22b, 22d, 22f, and 22g) exhibited anti-HDAC8 activity superior to PCI34051, a known HDAC8-specific inhibitor, with IC50 values in the range of 5-50nM. Among them, compound 22d showed antiproliferative effects toward several human lung cancer cell lines (A549, H1299, and CL1-5); it exhibited cytotoxicity against human lung CL1-5 cells similar to that of SAHA yet without significant cytotoxicity for normal IMR-90 cells. Expression profiling of HDAC isoforms in three cancer cell lines indicated that the HDAC8 level in CL1-5 is higher than that in H1299 and CL1-1 cells, a result consistent with the differential cytotoxicity of compound 22d. These results suggest the effectiveness of our design concept, which may lead to a tool compound for studying the specific role of HDAC8 in cellular biological processes.",
keywords = "Cinnamides, Epigenetics, Histone deacetylases, Isoform-selective inhibitors, Molecular modeling",
author = "Huang, {Wei Jan} and Wang, {Yi Ching} and Chao, {Shi Wei} and Yang, {Chen Yui} and Chen, {Liang Chieh} and Lin, {Mei Hsiang} and Hou, {Wen Chi} and Chen, {Mei Yu} and Lee, {Tai Lin} and Ping Yang and Chang, {Chung I.}",
year = "2012",
month = "10",
doi = "10.1002/cmdc.201200300",
language = "English",
volume = "7",
pages = "1815--1824",
journal = "ChemMedChem",
issn = "1860-7179",
publisher = "John Wiley and Sons Ltd",
number = "10",

}

TY - JOUR

T1 - Synthesis and Biological Evaluation of ortho-Aryl N-Hydroxycinnamides as Potent Histone Deacetylase (HDAC) 8 Isoform-Selective Inhibitors

AU - Huang, Wei Jan

AU - Wang, Yi Ching

AU - Chao, Shi Wei

AU - Yang, Chen Yui

AU - Chen, Liang Chieh

AU - Lin, Mei Hsiang

AU - Hou, Wen Chi

AU - Chen, Mei Yu

AU - Lee, Tai Lin

AU - Yang, Ping

AU - Chang, Chung I.

PY - 2012/10

Y1 - 2012/10

N2 - Histone deacetylases (HDACs) are a family of enzymes that play a crucial role in biological process and diseases. In contrast to other isozymes, HDAC8 is uniquely incapable of histone acetylation. In order to delineate its physiological function, we developed HDAC8-selective inhibitors using knowledge-based design combined with structural modeling techniques. Enzyme inhibitory analysis demonstrated that some of the resulting compounds (22b, 22d, 22f, and 22g) exhibited anti-HDAC8 activity superior to PCI34051, a known HDAC8-specific inhibitor, with IC50 values in the range of 5-50nM. Among them, compound 22d showed antiproliferative effects toward several human lung cancer cell lines (A549, H1299, and CL1-5); it exhibited cytotoxicity against human lung CL1-5 cells similar to that of SAHA yet without significant cytotoxicity for normal IMR-90 cells. Expression profiling of HDAC isoforms in three cancer cell lines indicated that the HDAC8 level in CL1-5 is higher than that in H1299 and CL1-1 cells, a result consistent with the differential cytotoxicity of compound 22d. These results suggest the effectiveness of our design concept, which may lead to a tool compound for studying the specific role of HDAC8 in cellular biological processes.

AB - Histone deacetylases (HDACs) are a family of enzymes that play a crucial role in biological process and diseases. In contrast to other isozymes, HDAC8 is uniquely incapable of histone acetylation. In order to delineate its physiological function, we developed HDAC8-selective inhibitors using knowledge-based design combined with structural modeling techniques. Enzyme inhibitory analysis demonstrated that some of the resulting compounds (22b, 22d, 22f, and 22g) exhibited anti-HDAC8 activity superior to PCI34051, a known HDAC8-specific inhibitor, with IC50 values in the range of 5-50nM. Among them, compound 22d showed antiproliferative effects toward several human lung cancer cell lines (A549, H1299, and CL1-5); it exhibited cytotoxicity against human lung CL1-5 cells similar to that of SAHA yet without significant cytotoxicity for normal IMR-90 cells. Expression profiling of HDAC isoforms in three cancer cell lines indicated that the HDAC8 level in CL1-5 is higher than that in H1299 and CL1-1 cells, a result consistent with the differential cytotoxicity of compound 22d. These results suggest the effectiveness of our design concept, which may lead to a tool compound for studying the specific role of HDAC8 in cellular biological processes.

KW - Cinnamides

KW - Epigenetics

KW - Histone deacetylases

KW - Isoform-selective inhibitors

KW - Molecular modeling

UR - http://www.scopus.com/inward/record.url?scp=84866756851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866756851&partnerID=8YFLogxK

U2 - 10.1002/cmdc.201200300

DO - 10.1002/cmdc.201200300

M3 - Article

C2 - 22907916

AN - SCOPUS:84866756851

VL - 7

SP - 1815

EP - 1824

JO - ChemMedChem

JF - ChemMedChem

SN - 1860-7179

IS - 10

ER -